Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total ...

Glutathione has been nicknamed the "master antioxidant," but some people are buying it online and self-injecting it, which ...

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...

Global small molecule API market will reach $360.0 billion by 2032, growing by 7.0% annually over 2022-2032, driven by the increasing incidences of diseases, the development of high-potency small ...

Lifearc has announced a collaboration with Neuropeutics Inc. to develop a new small molecule for the treatment of motor neuron disease (MND), or amyotrophic lateral sclerosis (ALS). Neuropeutics and ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...